Preliminary Scientific Program
17th INTERNATIONAL WAA & 3rd HRDS JOINT CONGRESS – ISTANBUL 2020
FRIDAY, APRIL 17th, 2020
08:30-09:30
- WAA BOARD OF DIRECTORS MEETING (by invitation only)
- NEW MEMBER AND FIRST TIME ATTENDEE MEET AND GREET
09:30-10:00 – OPENING CEREMONY
- WELCOME FROM THE PRESIDENT
- WELCOME FROM THE CONFERENCE CHAIR
- SCIENTIFIC SYMPOSIUM SPEAKERS will be announced soon…
10:00-12:15 – SCIENTIFIC SESSION: CAR-T CELL
10:00-11:00 – CAR-T CELL TECHNOLOGY
Chairs: will be announced soon…
Speakers: will be announced soon…
10:00-10:20 – Current status of CAR-T cell technologies
10:20-10:40 – Leukopheresis for CAR T-Cell Therapy: Mononuclear cell collection for engineered T-cells
10-40-11:00 – Processing, quality control and shipment of collected cells and manufacturing
11:00-11:15 – Coffee break
11:15-12:15 – CAR-T CELL & CLINICAL APPLICATIONS
Chairs: will be announced soon…
Speakers: will be announced soon…
11:15-11:35 – Real life experience in the treatment of ALL patients using commercially available CAR T cells
11:35-11:55 – Identifying the appropriate R/R DLBCL patient for CAR T cell therapy
11:55-12:15 – When to use CAR-T cells in Myeloma patients?
12:15-13:00 – Lunch Box
EDUCATION SYMPOSIUM SPEAKERS
- Dr. Gail RockDr.
- Vicencio Juárez Barreto
- Dr. William Clark
- Dr. Joseph Schwartz
- Dr. Hans Vrielink
- Dr. Guiqiang Wang
- Dr. Robert Weinstein
- Dr. Joachim Jankowski
- Dr. Miguel Lozano
- Dr. Christos Papadimitriou
- Dr. Angelina Mirasol
- Dr. Rakesh Srivastava
- Dr. Yossi Schwartz
- Dr. Kyou-Sup Han
- Dr. Rainer Moog
- Dr. Maria Luisa D. Concepcion
- Dr. Alfredo Mendrone Jr.
- Dr. Oliver Hequet
- Dr. Patrizia Accorsi
- Dr. Dima Tadeu Covas
- Dr. Bruce Sachais
- Dr. Thomas Groth
- Dr. Wladimir Szpirt
- Dr. Farhad Heshmati
- Dr. Ravi Sarode
13:00-14:00 EDUCATION SESSION-I: APHERESIS & TRANSPLANTATION
Chairs: will be announced soon
Speakers: will be announced soon
13:00-13:20 – Apheresis in Liver Transplantation & Liver Failure
13:20-13:40 – Role of ECP in Lung and Cardiac Transplantation
13:40-14:00 – What is the role of apheresis technology in stem cell transplantation?
14:00-14:15 – Coffee break
14:15-15:15 – EDUCATION SESSION-II: CHALLENGING ISSUES IN APHERESIS USE-I
Chairs: will be announced soon
Speakers: will be announced soon
14:15-14:35 – Red Cell Exchange Therapy for Sickle Cell Disease: Albumin Prime vs. Red Cell Prime
14:35-14:55 – Immunoadsorbsion and double filtration in clinical use: Why? When? Who?
14:55-15:15 – Lipoprotein apheresis: is it an optimal therapeutic option to reduce increased Lp(a) levels?
15:15-15:30 – Coffee break
15:30-16:50 – EDUCATION SESSION-III: DIFFERENT TOPICS IN APHERESIS
Chairs: will be announced soon
Speakers: will be announced soon
15:30-15:50 – Hemostasis Management Associated with Therapeutic Plasma Exchange
15:50-16:10 – Photopheresis in clinical use: How? When? Who?
16:10-16:30 – Performing Plasmapheresis on a Newborn
16:30-16:50 – Iron Deficiency in Apheresis Donors: RBC donors? Platelet donors? Plasma donors?
SATURDAY, APRIL 18th, 2020
07:30-08:30 – BREAKFAST WITH THE EXPERTS (Roundtable discussions)
08:30-09:30 – EDUCATION SESSION-IV: MANAGEMENT OF AN APHERESIS SESSION
Chairs: will be announced soon
Speakers: will be announced soon
08:30-08:50 – Influence of vascular access upon efficiency of therapeutic plasma exchange: Peripheral vein, central venous catheter, arterio-venous fistula, or implantable ports
08:50-09:10 – Anticoagulation Management in Therapeutic Plasma Exchange
09:10-09:30 – Replacement fluids in apheresis: what have changed?
09:30-09:50 – Coffee break
09:50 -10:00 – EDUCATION SESSION-V: APHERESIS IN DIFFERENT DISCIPLINES
Chairs: will be announced soon
Speakers: will be announced soon
10:00-10:20 – Advancing Apheresis in Neurology: Neurological Disease Indications for Plasma Exchange
10:20-10:40 – The treatment of ANCA-associated rapidly-progressive glomerulonephritis, Goodpasture syndrome, and antibody-mediated rejection in kidney transplantation with therapeutic apheresis
10:40-11:00 – Management of hypertriglyceridemia induced acute pancreatitis
11:00-11:15 – Coffee break
11:15-12:15 – EDUCATION SESSION-VI: CYTAPHERESIS
Chairs: will be announced soon
Speakers: will be announced soon
11:15-11:35 – Therapeutic erythroapheresis: Experience in patients with polycythemia vera and secondary erythrocytosis
11:35-11:55 – Characterization and indications of buffy coat-derived granulocytes for clinical use
11:55-12:15 – Plateletpheresis in Healthy Donors: Clinical considerations
12:15-13:00 – Lunch box
13:00-14:00 – EDUCATION SESSION-VII: APHERESIS IN THE FUTURE
Chairs: will be announced soon
Speakers: will be announced soon
13:00-13:20 – The role of plasma exchange in the management of autoimmune disorders
13:20-13:40 – Current and future treatment options for Thrombotic Thrombocytopenic Purpura
13:40-14:00 – Development of apheresis techniques and equipment designed for pediatric patients
14:00-14:15 – Coffee break
14:15-15:35 – EDUCATION SESSION-VIII: CHALLENGING ISSUES IN APHERESIS USE-II
Chairs: will be announced soon
Speakers: will be announced soon
14:15-14:35 – Adverse events in apheresis: How to manage them?
14:35-14:55 – Apheresis principles during pregnancy: are there challenges?
14:55-15:15 – Apheresis on advanced aged patients/donors with comorbidities
15:15-15:35 – Treatment of cryoglobulinemia with apheresis: How? When: Who?
SUNDAY, APRIL 19th, 2020
09:00-10:00 – POST-CONFERENCE ASFA BOARD OF DIRECTORS MEETING
10:00-12:00 – BOARD OF WAA/HRDS DIRECTORS AND SPONSORS MEETING
12:00-13:00 – CLOSING CEREMONY AND AWARDS